Exopolysaccharides Produced by <i>Bifidobacterium longum</i> subsp. <i>longum</i> YS108R Ameliorates DSS-Induced Ulcerative Colitis in Mice by Improving the Gut Barrier and Regulating the Gut Microbiota-Reference-Cited by-同舟云学术

Exopolysaccharides Produced by Bifidobacterium longum subsp. longum YS108R Ameliorates DSS-Induced Ulcerative Colitis in Mice by Improving the Gut Barrier and Regulating the Gut Microbiota

Published:2024-03-23 Issue:13 Volume:72 Page:7055-7073
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Li Huizhen¹²,Li Haitao¹²^ORCID,Stanton Catherine³⁴⁵,Ross R. Paul³⁴,Zhao Jianxin¹²,Chen Wei¹²⁶^ORCID,Yang Bo¹²³^ORCID

Affiliation:

1. State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, China

2. School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China

3. International Joint Research Center for Probiotics & Gut Health, Jiangnan University, Wuxi, Jiangsu 214122, China

4. APC Microbiome Ireland, University College Cork, Cork T12 K8AF, Ireland

5. Teagasc Food Research Centre, Moorepark, Fermoy, Cork P61 C996, Ireland

6. National Engineering Research Center for Functional Food, Jiangnan University, Wuxi, Jiangsu 214122, China

Funder

Collaborative Innovationcenter of Food Safety and Quality Control in Jiangsu Province

National Natural Science Foundation of China

111 Project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.3c06421

Reference113 articles.

1. Pathway paradigms revealed from the genetics of inflammatory bowel disease

2. Acute severe ulcerative colitis: from pathophysiology to clinical management

3. Ulcerative colitis

4. The metabolic nature of inflammatory bowel diseases

5. Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of gut microbiota in autoimmune diseases;Frontiers in Immunology;2024-05-03